{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:21:23Z","timestamp":1790508083773,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R21AI068881"],"award-info":[{"award-number":["1R21AI068881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.antiviral.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T17:22:59Z","timestamp":1434388979000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-8004","authenticated-orcid":false,"given":"Yuchen","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harilakshmi","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick I.","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.06.006_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jconrel.2006.09.011","article-title":"Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents","volume":"116","author":"Abes","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.antiviral.2015.06.006_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virusres.2011.02.011","article-title":"Molecular virology of hepatitis E virus","volume":"161","author":"Ahmad","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.06.006_b0015","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/bc070060v","article-title":"Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate","volume":"18","author":"Amantana","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.antiviral.2015.06.006_b0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/hgtb.2012.117","article-title":"Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen","volume":"23","author":"Anthony","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.antiviral.2015.06.006_b0025","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.02360-06","article-title":"Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models","volume":"81","author":"Burrer","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0030","series-title":"Virus Taxonomy, VIIIth Report of the ICTV","article-title":"Hepevirus","author":"Emerson","year":"2004"},{"key":"10.1016\/j.antiviral.2015.06.006_b0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","article-title":"Treatment of severe acute hepatitis E by ribavirin","volume":"52","author":"Gerolami","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0040","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1128\/JVI.79.11.6680-6689.2005","article-title":"The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques","volume":"79","author":"Graff","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0045","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1128\/JVI.00046-06","article-title":"A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus","volume":"80","author":"Graff","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0050","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1099\/0022-1317-82-10-2449","article-title":"Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States","volume":"82","author":"Haqshenas","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0055","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.02259-06","article-title":"Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo","volume":"81","author":"Huang","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399499001271","article-title":"Molecular biology and pathogenesis of hepatitis E virus","volume":"1999","author":"Jameel","year":"1999","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.antiviral.2015.06.006_b0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis E virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2015.06.006_b0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.06.006_b0075","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.06.006_b0080","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/j.ijid.2012.11.026","article-title":"Hepatitis E virus: the current scenario","volume":"17","author":"Kumar","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.06.006_b0085","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3201\/eid1112.051041","article-title":"Hepatitis E virus transmission from wild boar meat","volume":"11","author":"Li","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.06.006_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/rmv.482","article-title":"Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis","volume":"16","author":"Lu","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","article-title":"Brief communication: case reports of ribavirin treatment for chronic hepatitis E","volume":"153","author":"Mallet","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2015.06.006_b0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2893.2009.01257.x","article-title":"Recent advances in hepatitis E virus","volume":"17","author":"Meng","year":"2010","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.antiviral.2015.06.006_b0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2011.01.016","article-title":"From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety","volume":"161","author":"Meng","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.06.006_b0115","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1128\/JVI.72.12.9714-9721.1998","article-title":"Genetic and experimental evidence for cross-species infection by swine hepatitis E virus","volume":"72","author":"Meng","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0120","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.1073\/pnas.94.18.9860","article-title":"A novel virus in swine is closely related to the human hepatitis E virus","volume":"94","author":"Meng","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2015.06.006_b0125","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2174\/1381612811319160010","article-title":"In vivo delivery of morpholino oligos by cell-penetrating peptides","volume":"19","author":"Moulton","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2015.06.006_b0130","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1128\/JVI.01228-14","article-title":"Enhancement of interferon induction by ORF3 product of hepatitis E Virus","volume":"88","author":"Nan","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.virol.2012.05.015","article-title":"Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate","volume":"432","author":"Nan","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.06.006_b0140","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1128\/JVI.01935-14","article-title":"Hepatitis E virus inhibits type I interferon induction by ORF1 product","volume":"88","author":"Nan","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2008.03.032","article-title":"Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers","volume":"376","author":"Paessler","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.06.006_b0150","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1128\/JVI.00655-10","article-title":"Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1\/STAT2 nuclear translocation","volume":"84","author":"Patel","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0155","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2015.06.006_b0160","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1128\/JVI.74.17.8011-8017.2000","article-title":"Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies","volume":"74","author":"Riddell","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0165","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2015.06.006_b0170","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/vir.0.068429-0","article-title":"Consensus proposals for classification of the family Hepeviridae","volume":"95","author":"Smith","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0175","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2174\/138161208786071290","article-title":"Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers","volume":"14","author":"Stein","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2015.06.006_b0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2015.06.006_b0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","article-title":"Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome","volume":"185","author":"Tam","year":"1991","journal-title":"Virology"},{"issue":"1388\u20131397","key":"10.1016\/j.antiviral.2015.06.006_b0190","first-page":"e1381","article-title":"Pathogenesis and treatment of hepatitis E virus infection","volume":"142","author":"Wedemeyer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2015.06.006_b0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1535-7163.MCT-07-2036","article-title":"Blockade of viral interleukin-6 expression of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"7","author":"Zhang","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.antiviral.2015.06.006_b0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetmic.2006.06.006","article-title":"Suppression of porcine reproductive and respiratory syndrome virus replication by morpholino antisense oligomers","volume":"117","author":"Zhang","year":"2006","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2015.06.006_b0205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2006.05.017","article-title":"Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi\u2019s sarcoma-associated herpesvirus by morpholino oligomers","volume":"73","author":"Zhang","year":"2007","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T13:31:54Z","timestamp":1599139914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":41,"alternative-id":["S0166354215001370"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.06.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}